Kannan Sridharan, Muna Al Jufairi, Eman Al Ansari, Anfal Jasim, Diab Eltayeb Diab, Reem Al Marzooq, Abdulraoof Al Madhoob
Acetaminophen is gaining importance as a first-line drug for treating patent ductus arteriosus (PDA) in neonates. Predominant metabolites of acetaminophen in preterm neonates vary from that of adults; and the drug is predominantly metabolised by conjugation and partly by Cytochrome P450 (CYP) enzymes.We carried out the present study to identify the principal urine metabolites of acetaminophen (glucuronide/sulphate) in preterm neonates with hemodynamically significant PDA receiving intravenous acetaminophen, and to evaluate the prevalence of single nucleotide polymorphisms (SNPs) in the key CYP enzymes ( CYP1A2*3 , CYP1A2*4 , CYP1A2*1C, CYP1A2*1K, CYP1A2*6 , CYP2D6*10, CYP2E1*2 , CYP2E1*5B, CYP3A4*1B, CYP3A4*2 , CYP3A4*3 , CYP3A5*3, CYP3A5*7, and CYP3A5*11 ) and their effect on urinary metabolites and serum acetaminophen concentrations...
November 2021: Xenobiotica; the Fate of Foreign Compounds in Biological Systems